Home Applications 206089 Application 206089
Type NDA
Sponsor CLARUS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 JATENZO TESTOSTERONE UNDECANOATE CAPSULE;ORAL 158MG Yes No 002 JATENZO TESTOSTERONE UNDECANOATE CAPSULE;ORAL 198MG Yes No 003 JATENZO TESTOSTERONE UNDECANOATE CAPSULE;ORAL 237MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206089-001 JATENZO TESTOSTERONE UNDECANOATE 158MG CAPSULE / ORAL RLD 2019-03-27 N206089-002 JATENZO TESTOSTERONE UNDECANOATE 198MG CAPSULE / ORAL RLD 2019-03-27 N206089-003 JATENZO TESTOSTERONE UNDECANOATE 237MG CAPSULE / ORAL RLD, RS 2019-03-27
Orange Book patents# Current patent rows page 1 of 1 · 33 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 N206089-001 8778916 2030-04-12 Drug product 2019-04-08 N206089-001 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-001 11564933 2039-04-12 U-1103 2023-02-10 N206089-001 12605391 2039-04-12 U-1103 2026-04-24 N206089-002 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-002 11331325 2027-01-06 U-2506 2022-06-02 N206089-002 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-002 10543219 2030-04-12 U-2506 2020-02-18 N206089-002 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-002 11179403 2030-04-12 U-2506 2021-12-21 N206089-002 11426416 2030-04-12 U-3420 2022-09-12 N206089-002 8778916 2030-04-12 Drug product 2019-04-08 N206089-002 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-002 11564933 2039-04-12 U-1103 2023-02-10 N206089-002 12605391 2039-04-12 U-1103 2026-04-24 N206089-003 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-003 11331325 2027-01-06 U-2506 2022-06-02 N206089-003 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-003 10543219 2030-04-12 U-2506 2020-02-18 N206089-003 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-003 11179403 2030-04-12 U-2506 2021-12-21 N206089-003 11426416 2030-04-12 U-3420 2022-09-12 N206089-003 8778916 2030-04-12 Drug product 2019-04-08 N206089-003 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-003 11564933 2039-04-12 U-1103 2023-02-10 N206089-003 12605391 2039-04-12 U-1103 2026-04-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 8072bd15b7f6…
Observed Orange Book patent history# Patent history page 1 of 26 · 1,020 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 8778916 2030-04-12 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 8492369 2030-12-20 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-001 11564933 2039-04-12 U-1103 2023-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 11331325 2027-01-06 U-2506 2022-06-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 8241664 2029-03-29 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 10543219 2030-04-12 U-2506 2020-02-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 11179403 2030-04-12 U-2506 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 11426416 2030-04-12 U-3420 2022-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 8778916 2030-04-12 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 8492369 2030-12-20 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 11564933 2039-04-12 U-1103 2023-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 11331325 2027-01-06 U-2506 2022-06-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 8241664 2029-03-29 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 10543219 2030-04-12 U-2506 2020-02-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 11179403 2030-04-12 U-2506 2021-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 11426416 2030-04-12 U-3420 2022-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 8778916 2030-04-12 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 8492369 2030-12-20 U-2506 Drug product 2019-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 11564933 2039-04-12 U-1103 2023-02-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 8778916 2030-04-12 Drug product 2019-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 8492369 2030-12-20 U-2506 Drug product 2019-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 11564933 2039-04-12 U-1103 2023-02-10 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 51 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 69087-158 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current 69087-158 Jatenzo testosterone undecanoate TOLMAR Inc. NDA Current 69087-158 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current 69087-198 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current 69087-198 Jatenzo testosterone undecanoate TOLMAR Inc. NDA Current 69087-198 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current 69087-237 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current 69087-237 Jatenzo testosterone undecanoate TOLMAR Inc. NDA Current 69087-237 Jatenzo testosterone undecanoate Clarus Therapeutics, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 83353 SUPPL 2025-09-15 83352 SUPPL 2025-09-15 83351 SUPPL 2025-09-15 82874 SUPPL 2025-07-15 82843 SUPPL 2025-07-14 61042 ORIG 2019-11-25 58130 ORIG 2019-03-28 58097 ORIG 2019-03-27